The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET.
Katarzyna KuśnierzPaweł GutDariusz PawlakMaciej KolodziejLeszek KrólickiBeata Kos-KudlaMarek RuchalaGrzegorz KamińskiJolanta KunikowskaPublished in: International journal of endocrinology (2021)
The repeated therapy with [90Y]Y/[177Lu]Lu-DOTATATE is safe and effective for patients with disseminated, inoperable G1 and G2 neuroendocrine tumours.